Clinical Trial Update: Axillary Reverse Mapping for Breast Carcinomas [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating axillary reverse mapping in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Axillary Dissection | Phase 3 | Status: COMPLETED